GB9701459A
GB9701459D0
(en)
|
1997-01-24 |
1997-01-24 |
Therapeutic agents
|
EA199900045A
EA001574B1
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents.
|
IL12690097A
IL126900A0
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
US09/202,493
US6071927A
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
TR1998/02667T
TR199802667T2
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agent.
|
PL97330235A
PL330235A1
(en)
|
1996-06-21 |
1997-06-17 |
Derivatives of spiropiperidine and their application as therapeutic agents
|
SK1753-98A
SK175398A3
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
CZ984247A
CZ424798A3
(en)
|
1996-06-21 |
1997-06-17 |
Spiropiperidine derivatives, process of their preparation and pharmaceutical composition containing thereof
|
EP97926140A
EP0906315A1
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
KR1019980710463A
KR20000022060A
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
CA002257964A
CA2257964A1
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
NZ332777A
NZ332777A
(en)
|
1996-06-21 |
1997-06-17 |
3,6-bi-phenyl substituted spiro-piperidine derivatives
|
BR9709915A
BR9709915A
(en)
|
1996-06-21 |
1997-06-17 |
Compound pharmaceutical composition use of the compound and processes for the treatment or prevention of physiological disorders associated with an excess of tachykinins and for the preparation of the compound
|
AU31020/97A
AU722541B2
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
PCT/GB1997/001630
WO1997049710A1
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
YU59098A
YU59098A
(en)
|
1996-06-21 |
1997-06-17 |
Substituted spiro-piperidine derivatives
|
JP10502496A
JP2000510153A
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutics
|
EE9800459A
EE9800459A
(en)
|
1996-06-21 |
1997-06-17 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
EP97952024A
EP0942732B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating movement disorders
|
AT97952052T
ATE293975T1
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DISORDERS
|
JP52517098A
JP2001504848A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of severe anxiety disorder
|
DE69730515T
DE69730515T2
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENTS OF STRESS DISORDERS
|
PCT/EP1997/006683
WO1998024439A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating severe anxiety disorders
|
DE69732492T
DE69732492T2
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF HEAVY DEPRESSIONS ACCOMPANIED BY ANXIETY STATES
|
AU55594/98A
AU734872B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating movement disorders
|
EP97952023A
EP0942731B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating substance use disorders
|
DE69731657T
DE69731657T2
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SUBSTANCE USE ERRORS
|
PCT/EP1997/006688
WO1998024443A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating bipolar disorders
|
DE69731658T
DE69731658T2
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MOTION FLUCTUATIONS
|
PCT/EP1997/006691
WO1998024445A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating schizophrenic disorders
|
CA002273809A
CA2273809A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating movement disorders
|
ES97952019T
ES2234039T3
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEIVER ANTAGONISTS TO TREAT MORE DEPRESSION DISORDERS.
|
EP97952021A
EP0941093B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
|
JP52517498A
JP2001504852A
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonist for the treatment of bipolar disorder
|
AU54858/98A
AU731349B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating sexual dysfunctions
|
JP52517798A
JP2001507678A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of movement disorders
|
PCT/EP1997/006690
WO1998024444A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating substance use disorders
|
ES97952021T
ES2236838T3
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEPTOR ANTAPHONISTS FOR THE TREATMENT OF SERIOUS DEPRESSIVE DISORDERS WITH ANXIETY.
|
CA002273806A
CA2273806A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating substance use disorders
|
AU55613/98A
AU734860B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating cognitive disorders
|
PCT/EP1997/006692
WO1998024446A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating movement disorders
|
CA002273807A
CA2273807A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating schizophrenic disorders
|
ES97952023T
ES2231901T3
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEIVER ANTAGONISTS TO TREAT DISORDERS FOR THE USE OF SUBSTANCES.
|
ES97952020T
ES2227728T3
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEIVER ANTAGONISTS TO TREAT ESTS DISORDERS.
|
PCT/EP1997/006684
WO1998024440A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating stress disorders
|
JP52517398A
JP2001504851A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of sexual dysfunction
|
EP97952019A
EP0941092B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders
|
CA002273351A
CA2273351A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating sexual dysfunction
|
AT97952019T
ATE285776T1
(en)
|
1996-12-02 |
1997-11-25 |
METHOD AND DEVICE FOR COMPENSATING LUMINANCE DISTURBANCES CAUSED BY CHROME SIGNAL PROCESSING
|
CA002273785A
CA2273785A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating severe anxiety disorders
|
PCT/EP1997/006687
WO1998024442A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating sexual dysfunction
|
JP52516998A
JP2001504847A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of major depressive disorder
|
JP52517598A
JP2001504853A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of a substance use disorder
|
JP52517198A
JP2001504849A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of stress disorders
|
AU55592/98A
AU731672B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating bipolar disorders
|
PCT/EP1997/006682
WO1998024438A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders
|
EP97953721A
EP0942734A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating severe anxiety disorders
|
EP97951270A
EP0942728A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating sexual dysfunction
|
DK97952020T
DK0942729T3
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for the treatment of stress disorders
|
AT97952020T
ATE274908T1
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENTS OF STRESS DISORDERS
|
DE69733148T
DE69733148T2
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DISORDER
|
PT97952020T
PT942729E
(en)
|
1996-12-02 |
1997-11-25 |
UTILIZATION OF NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF STRESSE DISEASES
|
EP97952020A
EP0942729B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating stress disorders
|
AU55589/98A
AU733855B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating major depressive disorders
|
CA002273810A
CA2273810A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders
|
AU55593/98A
AU731674B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating substance use disorders
|
AU55590/98A
AU731676B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating stress disorders
|
CA002273856A
CA2273856A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating bipolar disorders
|
AU57527/98A
AU729708B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating severe anxiety disorders
|
EP97952022A
EP0942730A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating bipolar disorders
|
AT97952021T
ATE288756T1
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEPTOR ANTAGONISTS TO TREAT SEVERE DEPRESSION ACCOMPANIED BY ANXIETY
|
EP97952052A
EP0942733B1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating cognitive disorders
|
CA002273786A
CA2273786A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating stress disorders
|
AT97952024T
ATE282417T1
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MOVEMENT DISORDERS
|
PCT/EP1997/006940
WO1998024447A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating cognitive disorders
|
JP52517298A
JP2001504850A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist to treat severe depressive disorder with anxiety
|
AU55591/98A
AU736042B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
|
JP52522398A
JP2001508412A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist for the treatment of cognitive impairment
|
CA002273853A
CA2273853A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating cognitive disorders
|
CA002273800A
CA2273800A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
|
AU57530/98A
AU732633B2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for treating schizophrenic disorders
|
AT97952023T
ATE282416T1
(en)
|
1996-12-02 |
1997-11-25 |
THE USE OF NK-1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF SUBSTANCE USE DISORDERS
|
JP52517698A
JP2001505881A
(en)
|
1996-12-02 |
1997-11-25 |
Use of an NK-1 receptor antagonist to treat schizophrenia disease
|
PCT/EP1997/006686
WO1998024441A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating major depressive disorders with anxiety
|
DE69732133T
DE69732133T2
(en)
|
1996-12-02 |
1997-11-25 |
Use of NK-1 receptor antagonists for the treatment of major depression
|
EP97953724A
EP0942735A1
(en)
|
1996-12-02 |
1997-11-25 |
Use of nk-1 receptor antagonists for treating schizophrenic disorders
|
ES97952024T
ES2231902T3
(en)
|
1996-12-02 |
1997-11-25 |
USE OF NK-1 RECEIVER ANTAGONISTS FOR THE TREATMENT OF MOVEMENT DISORDERS.
|
TW086117779A
TW466240B
(en)
|
1996-06-21 |
1997-11-26 |
Spiro-piperidine derivatives and pharmaceutical composition comprising the same
|
IDP973779A
ID19017A
(en)
|
1996-12-02 |
1997-11-27 |
SPIRO-PIPERIDIN DECREASES AND THE USE OF THERAPEUTIC MATERIALS
|
US08/980,928
US6096729A
(en)
|
1996-12-02 |
1997-12-01 |
Use of NK-1 receptor antagonists for treating amnestic disorders
|
US08/982,053
US5952315A
(en)
|
1996-12-02 |
1997-12-01 |
Use of NK-1 receptor antagonists for treating bipolar disorders
|
PE00108297A
PE20099A1
(en)
|
1996-12-02 |
1997-12-01 |
DERIVATIVES OF SPIRO-PIPERIDINE AND ITS USE AS THERAPEUTIC AGENTS
|
HRP970648
HRP970648A2
(en)
|
1996-12-02 |
1997-12-01 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
US08/980,931
US5925627A
(en)
|
1996-12-02 |
1997-12-01 |
Use of NK-1 receptor antagonists for treating movement disorders
|
CO97070178A
CO4910154A1
(en)
|
1996-12-02 |
1997-12-01 |
DERIVATIVES OF SPIRO-PIPERIDINE AND THEIR USE AS TERA-PEUTICAL AGENTS
|
US08/980,730
US5929054A
(en)
|
1996-12-02 |
1997-12-01 |
Use of NK-1 receptor antagonists for treating sexual dysfunctions
|
US08/980,927
US5919781A
(en)
|
1996-12-02 |
1997-12-01 |
Use of NK-1 receptor antogonists for treating substance use disorders
|
US09/096,414
US5977104A
(en)
|
1996-12-02 |
1998-06-11 |
Use of NK-1 receptor antagonists for treating bipolar disorders
|
US09/096,039
US6613765B1
(en)
|
1996-12-02 |
1998-06-11 |
Use of NK-1 receptor antagonists for treating major depressive disorders
|
US09/096,216
US6114315A
(en)
|
1996-12-02 |
1998-06-11 |
Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
|
US09/095,782
US6100256A
(en)
|
1996-12-02 |
1998-06-11 |
Use of NK-1 receptors antagonists for treating schizophrenic disorders
|
BG102998A
BG102998A
(en)
|
1996-06-21 |
1998-12-08 |
Spiro-piperidine derivatives and their application as therapeutical forms
|
NO985977A
NO985977L
(en)
|
1996-06-21 |
1998-12-18 |
Spiro-piperidine derivatives and their use as therapeutic agents
|
CY0500004A
CY2499B1
(en)
|
1996-12-02 |
2005-01-10 |
Use of nk-1 receptor antagonists for treating stress disorders.
|